Symbol of the Government of Canada

Common menu bar links

Hoffmann-La Roche Limited

Submission — Hoffmann-La Roche Limited

Important note: The content of submissions and summaries is the sole responsibility of the person and / or organization having made a submission. The posting of this content does not indicate that the Panel supports or endorses it. Submissions and summaries are posted in the language provided without modification.

Submitter(s): Torontali, Ilona

Summary: Roche Canada is pleased to provide this submission to the Expert Review Panel on Research and Development. Innovation is at the core of our company and at Roche, we focus on the creation and commercialisation of medically differentiated products and services that lead to tangible improvements in the health, quality of life and survival of patients. We believe that there are a number of opportunities for Canadian policy makers to improve private sector R&D investment into Canada through creating a strong and efficient regulatory and Intellectual Property system, by urgently moving to improve our clinical research competitiveness and through supporting increased partnerships between private and public research organizations.

Full submission: PDF Version